Create and preserve: Proteostasis in development and aging is governed by Cdc48/p97/VCP

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 1, 2014, Pages 205-215

  Franz, André ^a   Ackermann, Leena ^a   Hoppe, Thorsten ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Age related disease; Autophagy; Cdc48 CDC 48 p97 VCP; Protein aggregation; Proteostasis; Ubiquitin proteasome system

Indexed keywords

CELL CYCLE PROTEIN; CELL DIVISION CYCLE PROTEIN 48; UNCLASSIFIED DRUG;

AGING; AMYOTROPHIC LATERAL SCLEROSIS; AUTOPHAGY; CAENORHABDITIS ELEGANS; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DIVISION; CELL MIGRATION; CELL PROLIFERATION; CHROMOSOME SEGREGATION; CLINICAL FEATURE; DEVELOPMENT; DNA REPAIR; DOUBLE STRANDED DNA BREAK; ENDOPLASMIC RETICULUM; FRONTOTEMPORAL DEMENTIA; GAMETOGENESIS; GENOMIC INSTABILITY; GERM CELL; HUMAN; LIFESPAN; MITOCHONDRIAL MEMBRANE; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PAGET BONE DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN HOMEOSTASIS; PROTEIN QUALITY; REPRODUCTION; REVIEW; SEX DETERMINATION; STRESS; UBIQUITINATION;

EID: 84890229110     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.03.031     Document Type: Review

References (178)

1. Mizushima N. Autophagy: process and function. Genes Dev. 2007, 21:2861-2873.
2. Kikis E.A., Gidalevitz T., Morimoto R.I. Protein homeostasis in models of aging and age-related conformational disease. Adv. Exp. Med. Biol. 2010, 694:138-159.
3. Scheffner M., Nuber U., Huibregtse J.M. Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature 1995, 373:81-83.
4. Koegl M., Hoppe T., Schlenker S., Ulrich H.D., Mayer T.U., Jentsch S. A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 1999, 96:635-644.
5. Hoppe T. Multiubiquitylation by E4 enzymes: 'one size' doesn't fit all. Trends Biochem. Sci. 2005, 30:183-187.
6. Chau V., Tobias J.W., Bachmair A., Marriott D., Ecker D.J., Gonda D.K., Varshavsky A. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 1989, 243:1576-1583.
7. Thrower J.S., Hoffman L., Rechsteiner M., Pickart C.M. Recognition of the polyubiquitin proteolytic signal. EMBO J. 2000, 19:94-102.
8. Wojcik C., DeMartino G.N. Intracellular localization of proteasomes. Int. J. Biochem. Cell Biol. 2003, 35:579-589.
9. Komander D., Rape M. The ubiquitin code. Annu. Rev. Biochem. 2012, 81:203-229.
10. Mukhopadhyay D., Riezman H. Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science 2007, 315:201-205.
11. VanDemark A.P., Hofmann R.M., Tsui C., Pickart C.M., Wolberger C. Molecular insights into polyubiquitin chain assembly: crystal structure of the Mms2/Ubc13 heterodimer. Cell 2001, 105:711-720.
12. Richly H., Rape M., Braun S., Rumpf S., Hoege C., Jentsch S. A series of ubiquitin binding factors connects CDC48/p97 to substrate multiubiquitylation and proteasomal targeting. Cell 2005, 120:73-84.
13. Ammelburg M., Frickey T., Lupas A.N. Classification of AAA+ proteins. J. Struct. Biol. 2006, 156:2-11.
14. Beuron F., Dreveny I., Yuan X., Pye V.E., McKeown C., Briggs L.C., Cliff M.J., Kaneko Y., Wallis R., Isaacson R.L., Ladbury J.E., Matthews S.J., Kondo H., Zhang X., Freemont P.S. Conformational changes in the AAA ATPase p97-p47 adaptor complex. EMBO J. 2006, 25:1967-1976.
15. Rouiller I., DeLaBarre B., May A.P., Weis W.I., Brunger A.T., Milligan R.A., Wilson-Kubalek E.M. Conformational changes of the multifunction p97 AAA ATPase during its ATPase cycle. Nat. Struct. Biol. 2002, 9:950-957.
16. Pye V.E., Dreveny I., Briggs L.C., Sands C., Beuron F., Zhang X., Freemont P.S. Going through the motions: the ATPase cycle of p97. J. Struct. Biol. 2006, 156:12-28.
17. Beskow A., Grimberg K.B., Bott L.C., Salomons F.A., Dantuma N.P., Young P. A conserved unfoldase activity for the p97 AAA-ATPase in proteasomal degradation. J. Mol. Biol. 2009, 394:732-746.
18. Ramadan K., Bruderer R., Spiga F.M., Popp O., Baur T., Gotta M., Meyer H.H. Cdc48/p97 promotes reformation of the nucleus by extracting the kinase Aurora B from chromatin. Nature 2007, 450:1258-1262.
19. Ramanathan H.N., Ye Y. The p97 ATPase associates with EEA1 to regulate the size of early endosomes. Cell Res. 2011, 22:346-359.
20. Wilcox A.J., Laney J.D. A ubiquitin-selective AAA-ATPase mediates transcriptional switching by remodelling a repressor-promoter DNA complex. Nat. Cell Biol. 2009, 11:1481-1486.
21. Barthelme D., Sauer R.T. Identification of the Cdc48*20S proteasome as an ancient AAA+ proteolytic machine. Science 2012, 337:843-846.
22. Barthelme D., Sauer R.T. Bipartite determinants mediate an evolutionarily conserved interaction between Cdc48 and the 20S peptidase. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:3327-3332.
23. Peters J.M., Walsh M.J., Franke W.W. An abundant and ubiquitous homo-oligomeric ring-shaped ATPase particle related to the putative vesicle fusion proteins Sec18p and NSF. EMBO J. 1990, 9:1757-1767.
24. Ghislain M., Dohmen R.J., Levy F., Varshavsky A. Cdc48p interacts with Ufd3p, a WD repeat protein required for ubiquitin-mediated proteolysis in Saccharomyces cerevisiae. EMBO J. 1996, 15:4884-4899.
25. Bug M., Meyer H. Expanding into new markets-VCP/p97 in endocytosis and autophagy. J. Struct. Biol. 2012, 179:78-82.
26. Meyer H., Bug M., Bremer S. Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system. Nat. Cell Biol. 2012, 14:117-123.
27. Yamanaka K., Sasagawa Y., Ogura T. Recent advances in p97/VCP/Cdc48 cellular functions. Biochim. Biophys. Acta 2011, 1823:130-137.
28. Deichsel A., Mouysset J., Hoppe T. The ubiquitin-selective chaperone CDC-48/p97, a new player in DNA replication. Cell Cycle 2009, 8:185-190.
29. Stolz A., Hilt W., Buchberger A., Wolf D.H. Cdc48: a power machine in protein degradation. Trends Biochem. Sci. 2011, 36:515-523.
30. Ye Y. Diverse functions with a common regulator: ubiquitin takes command of an AAA ATPase. J. Struct. Biol. 2006, 156:29-40.
31. Schuberth C., Buchberger A. UBX domain proteins: major regulators of the AAA ATPase Cdc48/p97. Cell. Mol. Life Sci. 2008, 65:2360-2371.
32. Rumpf S., Jentsch S. Functional division of substrate processing cofactors of the ubiquitin-selective Cdc48 chaperone. Mol. Cell 2006, 21:261-269.
33. Kondo H., Rabouille C., Newman R., Levine T.P., Pappin D., Freemont P., Warren G. p47 is a cofactor for p97-mediated membrane fusion. Nature 1997, 388:75-78.
34. Meyer H.H., Wang Y., Warren G. Direct binding of ubiquitin conjugates by the mammalian p97 adaptor complexes, p47 and Ufd1-Npl4. EMBO J. 2002, 21:5645-5652.
35. Kuhlbrodt K., Janiesch P.C., Kevei E., Segref A., Barikbin R., Hoppe T. The Machado-Joseph disease deubiquitylase ATX-3 couples longevity and proteostasis. Nat. Cell Biol. 2011, 13:273-281.
36. Sowa M.E., Bennett E.J., Gygi S.P., Harper J.W. Defining the human deubiquitinating enzyme interaction landscape. Cell 2009, 138:389-403.
37. Karabinova P., Kubelka M., Susor A. Proteasomal degradation of ubiquitinated proteins in oocyte meiosis and fertilization in mammals. Cell Tissue Res. 2011, 346:1-9.
38. Sasagawa Y., Yamanaka K., Nishikori S., Ogura T. Caenorhabditis elegans p97/CDC-48 is crucial for progression of meiosis I. Biochem. Biophys. Res. Commun. 2007, 358:920-924.
39. Sasagawa Y., Higashitani A., Urano T., Ogura T., Yamanaka K. CDC-48/p97 is required for proper meiotic chromosome segregation via controlling AIR-2/Aurora B kinase localization in Caenorhabditis elegans. J. Struct. Biol. 2012, 179:104-111.
40. Dobrynin G., Popp O., Romer T., Bremer S., Schmitz M.H., Gerlich D.W., Meyer H. Cdc48/p97-Ufd1-Npl4 antagonizes Aurora B during chromosome segregation in HeLa cells. J. Cell Sci. 2011, 124:1571-1580.
41. Bohm S., Buchberger A. The budding yeast cdc48(shp1) complex promotes cell cycle progression by positive regulation of protein phosphatase 1 (glc7). PLoS One 2013, 8:e56486.
42. Heallen T.R., Adams H.P., Furuta T., Verbrugghe K.J., Schumacher J.M. An Afg2/Spaf-related Cdc48-like AAA ATPase regulates the stability and activity of the C. elegans Aurora B kinase AIR-2. Dev. Cell 2008, 15:603-616.
43. Mouysset J., Deichsel A., Moser S., Hoege C., Hyman A.A., Gartner A., Hoppe T. Cell cycle progression requires the CDC-48UFD-1/NPL-4 complex for efficient DNA replication. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:12879-12884.
44. Kappel L., Loibl M., Zisser G., Klein I., Fruhmann G., Gruber C., Unterweger S., Rechberger G., Pertschy B., Bergler H. Rlp24 activates the AAA-ATPase Drg1 to initiate cytoplasmic pre-60S maturation. J. Cell Biol. 2012, 199:771-782.
45. Pertschy B., Saveanu C., Zisser G., Lebreton A., Tengg M., Jacquier A., Liebminger E., Nobis B., Kappel L., van der Klei I., Hogenauer G., Fromont-Racine M., Bergler H. Cytoplasmic recycling of 60S preribosomal factors depends on the AAA protein Drg1. Mol. Cell. Biol. 2007, 27:6581-6592.
46. Thorsness P.E., White K.H., Ong W.C. AFG2, an essential gene in yeast, encodes a new member of the Sec18p, Pas1p, Cdc48p, TBP-1 family of putative ATPases. Yeast 1993, 9:1267-1271.
47. Moir D., Stewart S.E., Osmond B.C., Botstein D. Cold-sensitive cell-division-cycle mutants of yeast: isolation, properties, and pseudoreversion studies. Genetics 1982, 100:547-563.
48. Cheng Y.L., Chen R.H. The AAA-ATPase Cdc48 and cofactor Shp1 promote chromosome bi-orientation by balancing Aurora B activity. J. Cell Sci. 2010, 123:2025-2034.
49. Cao K., Nakajima R., Meyer H.H., Zheng Y. The AAA-ATPase Cdc48/p97 regulates spindle disassembly at the end of mitosis. Cell 2003, 115:355-367.
50. Heubes S., Stemmann O. The AAA-ATPase p97-Ufd1-Npl4 is required for ERAD but not for spindle disassembly in Xenopus egg extracts. J. Cell Sci. 2007, 120:1325-1329.
51. Ikai N., Yanagida M. Cdc48 is required for the stability of Cut1/separase in mitotic anaphase. J. Struct. Biol. 2006, 156:50-61.
52. Franz A., Orth M., Pirson P.A., Sonneville R., Blow J.J., Gartner A., Stemmann O., Hoppe T. CDC-48/p97 coordinates CDT-1 degradation with GINS chromatin dissociation to ensure faithful DNA replication. Mol. Cell 2011, 44:85-96.
53. Raman M., Havens C.G., Walter J.C., Harper J.W. A genome-wide screen identifies p97 as an essential regulator of DNA damage-dependent CDT1 destruction. Mol. Cell 2011, 44:72-84.
54. Blow J.J., Gillespie P.J. Replication licensing and cancer-a fatal entanglement?. Nat. Rev. Cancer 2008, 8:799-806.
55. Tatsumi Y., Sugimoto N., Yugawa T., Narisawa-Saito M., Kiyono T., Fujita M. Deregulation of Cdt1 induces chromosomal damage without rereplication and leads to chromosomal instability. J. Cell Sci. 2006, 119:3128-3140.
56. Acs K., Luijsterburg M.S., Ackermann L., Salomons F.A., Hoppe T., Dantuma N.P. The AAA-ATPase VCP/p97 promotes 53BP1 recruitment by removing L3MBTL1 from DNA double-strand breaks. Nat. Struct. Mol. Biol. 2011, 18:1345-1350.
57. Meerang M., Ritz D., Paliwal S., Garajova Z., Bosshard M., Mailand N., Janscak P., Hubscher U., Meyer H., Ramadan K. The ubiquitin-selective segregase VCP/p97 orchestrates the response to DNA double-strand breaks. Nat. Cell Biol. 2011, 13:1376-1382.
58. Mosbech A., Gibbs-Seymour I., Kagias K., Thorslund T., Beli P., Povlsen L., Nielsen S.V., Smedegaard S., Sedgwick G., Lukas C., Hartmann-Petersen R., Lukas J., Choudhary C., Pocock R., Bekker-Jensen S., Mailand N. DVC1 (C1orf124) is a DNA damage-targeting p97 adaptor that promotes ubiquitin-dependent responses to replication blocks. Nat. Struct. Mol. Biol. 2012, 19:1084-1092.
59. Nie M., Aslanian A., Prudden J., Heideker J., Vashisht A.A., Wohlschlegel J.A., Yates J.R., Boddy M.N. Dual recruitment of Cdc48 (p97)-Ufd1-Npl4 ubiquitin-selective segregase by small ubiquitin-like modifier protein (SUMO) and ubiquitin in SUMO-targeted ubiquitin ligase-mediated genome stability functions. J. Biol. Chem. 2012, 287:29610-29619.
60. Verma R., Oania R., Fang R., Smith G.T., Deshaies R.J. Cdc48/p97 mediates UV-dependent turnover of RNA Pol II. Mol. Cell 2011, 41:82-92.
61. Davis E.J., Lachaud C., Appleton P., Macartney T.J., Nathke I., Rouse J. DVC1 (C1orf124) recruits the p97 protein segregase to sites of DNA damage. Nat. Struct. Mol. Biol. 2012, 11:1093-1100.
62. Ramadan K. p97/VCP- and Lys48-linked polyubiquitination form a new signaling pathway in DNA damage response. Cell Cycle 2012, 11:1062-1069.
63. Dantuma N.P., Hoppe T. Growing sphere of influence: Cdc48/p97 orchestrates ubiquitin-dependent extraction from chromatin. Trends Cell Biol. 2012, 22:483-491.
64. Sasagawa Y., Otani M., Higashitani N., Higashitani A., Sato K., Ogura T., Yamanaka K. Caenorhabditis elegans p97 controls germline-specific sex determination by controlling the TRA-1 level in a CUL-2-dependent manner. J. Cell Sci. 2009, 122:3663-3672.
65. Sasagawa Y., Yamanaka K., Saito-Sasagawa Y., Ogura T. Caenorhabditis elegans UBX cofactors for CDC-48/p97 control spermatogenesis. Genes Cells 2010, 15:1201-1215.
66. Hoppe T., Matuschewski K., Rape M., Schlenker S., Ulrich H.D., Jentsch S. Activation of a membrane-bound transcription factor by regulated ubiquitin/proteasome-dependent processing. Cell 2000, 102:577-586.
67. Rape M., Hoppe T., Gorr I., Kalocay M., Richly H., Jentsch S. Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone. Cell 2001, 107:667-677.
68. Alexandru G., Graumann J., Smith G.T., Kolawa N.J., Fang R., Deshaies R.J. UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover. Cell 2008, 134:804-816.
69. Bandau S., Knebel A., Gage Z.O., Wood N.T., Alexandru G. UBXN7 docks on neddylated cullin complexes using its UIM motif and causes HIF1alpha accumulation. BMC Biol. 2012, 10:36.
70. Kim J., Lowe T., Hoppe T. Protein quality control gets muscle into shape. Trends Cell Biol. 2008, 18:264-272.
71. Barral J.M., Hutagalung A.H., Brinker A., Hartl F.U., Epstein H.F. Role of the myosin assembly protein UNC-45 as a molecular chaperone for myosin. Science 2002, 295:669-671.
72. Hoppe T., Cassata G., Barral J.M., Springer W., Hutagalung A.H., Epstein H.F., Baumeister R. Regulation of the myosin-directed chaperone UNC-45 by a novel E3/E4-multiubiquitylation complex in C. elegans. Cell 2004, 118:337-349.
73. Landsverk M.L., Li S., Hutagalung A.H., Najafov A., Hoppe T., Barral J.M., Epstein H.F. The UNC-45 chaperone mediates sarcomere assembly through myosin degradation in Caenorhabditis elegans. J. Cell Biol. 2007, 177:205-210.
74. Janiesch P.C., Kim J., Mouysset J., Barikbin R., Lochmuller H., Cassata G., Krause S., Hoppe T. The ubiquitin-selective chaperone CDC-48/p97 links myosin assembly to human myopathy. Nat. Cell Biol. 2007, 9:379-390.
75. Piccirillo R., Goldberg A.L. The p97/VCP ATPase is critical in muscle atrophy and the accelerated degradation of muscle proteins. EMBO J. 2012, 31:3334-3350.
76. Chang Y.C., Hung W.T., Chang H.C., Wu C.L., Chiang A.S., Jackson G.R., Sang T.K. Pathogenic VCP/TER94 alleles are dominant actives and contribute to neurodegeneration by altering cellular ATP level in a Drosophila IBMPFD model. PLoS Genet. 2011, 7:e1001288.
77. Custer S.K., Neumann M., Lu H., Wright A.C., Taylor J.P. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone. Hum. Mol. Genet. 2010, 19:1741-1755.
78. Weihl C.C., Miller S.E., Hanson P.I., Pestronk A. Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice. Hum. Mol. Genet. 2007, 16:919-928.
79. Hubbers C.U., Clemen C.S., Kesper K., Boddrich A., Hofmann A., Kamarainen O., Tolksdorf K., Stumpf M., Reichelt J., Roth U., Krause S., Watts G., Kimonis V., Wattjes M.P., Reimann J., Thal D.R., Biermann K., Evert B.O., Lochmuller H., Wanker E.E., Schoser B.G., Noegel A.A., Schroder R. Pathological consequences of VCP mutations on human striated muscle. Brain 2007, 130:381-393.
80. Rumpf S., Lee S.B., Jan L.Y., Jan Y.N. Neuronal remodeling and apoptosis require VCP-dependent degradation of the apoptosis inhibitor DIAP1. Development 2011, 138:1153-1160.
81. Wang H.F., Shih Y.T., Chen C.Y., Chao H.W., Lee M.J., Hsueh Y.P. Valosin-containing protein and neurofibromin interact to regulate dendritic spine density. J. Clin. Invest. 2011, 121:4820-4837.
82. Weihl C.C. Another VCP interactor: NF is enough. J. Clin. Invest. 2011, 121:4627-4630.
83. Leon A., McKearin D. Identification of TER94, an AAA ATPase protein, as a Bam-dependent component of the Drosophila fusome. Mol. Biol. Cell 1999, 10:3825-3834.
84. Ruden D.M., Sollars V., Wang X., Mori D., Alterman M., Lu X. Membrane fusion proteins are required for oskar mRNA localization in the Drosophila egg chamber. Dev. Biol. 2000, 218:314-325.
85. Roth S., Stein D., Nusslein-Volhard C. A gradient of nuclear localization of the dorsal protein determines dorsoventral pattern in the Drosophila embryo. Cell 1989, 59:1189-1202.
86. Dai R.M., Chen E., Longo D.L., Gorbea C.M., Li C.C. Involvement of valosin-containing protein, an ATPase co-purified with IkappaBalpha and 26S proteasome, in ubiquitin-proteasome-mediated degradation of IkappaBalpha. J. Biol. Chem. 1998, 273:3562-3573.
87. Park M.Y., Jang H.D., Lee S.Y., Lee K.J., Kim E. Fas-associated factor-1 inhibits nuclear factor-kappaB (NF-kappaB) activity by interfering with nuclear translocation of the RelA (p65) subunit of NF-kappaB. J. Biol. Chem. 2004, 279:2544-2549.
88. Park M.Y., Moon J.H., Lee K.S., Choi H.I., Chung J., Hong H.J., Kim E. FAF1 suppresses IkappaB kinase (IKK) activation by disrupting the IKK complex assembly. J. Biol. Chem. 2007, 282:27572-27577.
89. David D.C. Aging and the aggregating proteome. Front. Genet. 2012, 3:247.
90. Martin G.M. The genetics and epigenetics of altered proliferative homeostasis in ageing and cancer. Mech. Ageing Dev. 2007, 128:9-12.
91. Calderwood S.K., Murshid A., Prince T. The shock of aging: molecular chaperones and the heat shock response in longevity and aging-a mini-review. Gerontology 2009, 55:550-558.
92. Kenyon C.J. The genetics of ageing. Nature 2010, 464:504-512.
93. Shore D.E., Carr C.E., Ruvkun G. Induction of cytoprotective pathways is central to the extension of lifespan conferred by multiple longevity pathways. PLoS Genet. 2012, 8:e1002792.
94. Rodriguez M., Snoek L.B., De Bono M., Kammenga J.E. Worms under stress: C. elegans stress response and its relevance to complex human disease and aging. Trends Genet. 2013, in press. 10.1016/j.tig.2013.01.010.
95. Heo J.M., Livnat-Levanon N., Taylor E.B., Jones K.T., Dephoure N., Ring J., Xie J., Brodsky J.L., Madeo F., Gygi S.P., Ashrafi K., Glickman M.H., Rutter J. A stress-responsive system for mitochondrial protein degradation. Mol. Cell 2010, 40:465-480.
96. Rubinsztein D.C., Marino G., Kroemer G. Autophagy and aging. Cell 2011, 146:682-695.
97. Brown M.K., Naidoo N. The endoplasmic reticulum stress response in aging and age-related diseases. Front. Physiol. 2012, 3:263.
98. Wolf D.H., Stolz A. The Cdc48 machine in endoplasmic reticulum associated protein degradation. Biochim. Biophys. Acta 2012, 1823:117-124.
99. Lim P.J., Danner R., Liang J., Doong H., Harman C., Srinivasan D., Rothenberg C., Wang H., Ye Y., Fang S., Monteiro M.J. Ubiquilin and p97/VCP bind erasin, forming a complex involved in ERAD. J. Cell Biol. 2009, 187:201-217.
100. Schuberth C., Buchberger A. Membrane-bound Ubx2 recruits Cdc48 to ubiquitin ligases and their substrates to ensure efficient ER-associated protein degradation. Nat. Cell Biol. 2005, 7:999-1006.
101. Neuber O., Jarosch E., Volkwein C., Walter J., Sommer T. Ubx2 links the Cdc48 complex to ER-associated protein degradation. Nat. Cell Biol. 2005, 7:993-998.
102. Madsen L., Kriegenburg F., Vala A., Best D., Prag S., Hofmann K., Seeger M., Adams I.R., Hartmann-Petersen R. The tissue-specific Rep8/UBXD6 tethers p97 to the endoplasmic reticulum membrane for degradation of misfolded proteins. PLoS One 2011, 6:e25061.
103. Sasagawa Y., Yamanaka K., Ogura T. ER E3 ubiquitin ligase HRD-1 and its specific partner chaperone BiP play important roles in ERAD and developmental growth in Caenorhabditis elegans. Genes Cells 2007, 12:1063-1073.
104. Mouysset J., Kahler C., Hoppe T. A conserved role of Caenorhabditis elegans CDC-48 in ER-associated protein degradation. J. Struct. Biol. 2006, 156:41-49.
105. Duennwald M.L., Lindquist S. Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity. Genes Dev. 2008, 22:3308-3319.
106. Taylor E.B., Rutter J. Mitochondrial quality control by the ubiquitin-proteasome system. Biochem. Soc. Trans. 2011, 39:1509-1513.
107. Esaki M., Ogura T. Cdc48p/p97-mediated regulation of mitochondrial morphology is Vms1p-independent. J. Struct. Biol. 2012, 179:112-120.
108. Xu S., Peng G., Wang Y., Fang S., Karbowski M. The AAA-ATPase p97 is essential for outer mitochondrial membrane protein turnover. Mol. Biol. Cell 2011, 22:291-300.
109. Ziviani E., Tao R.N., Whitworth A.J. Drosophila parkin requires PINK1 for mitochondrial translocation and ubiquitinates mitofusin. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:5018-5023.
110. Tanaka A., Cleland M.M., Xu S., Narendra D.P., Suen D.F., Karbowski M., Youle R.J. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J. Cell Biol. 2010, 191:1367-1380.
111. Weidberg H., Shvets E., Elazar Z. Biogenesis and cargo selectivity of autophagosomes. Annu. Rev. Biochem. 2011, 80:125-156.
112. Stipanuk M.H. Macroautophagy and its role in nutrient homeostasis. Nutr. Rev. 2009, 67:677-689.
113. Kirkin V., Lamark T., Johansen T., Dikic I. NBR1 cooperates with p62 in selective autophagy of ubiquitinated targets. Autophagy 2009, 5:732-733.
114. Ju J.S., Fuentealba R.A., Miller S.E., Jackson E., Piwnica-Worms D., Baloh R.H., Weihl C.C. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J. Cell Biol. 2009, 187:875-888.
115. Tresse E., Salomons F.A., Vesa J., Bott L.C., Kimonis V., Yao T.P., Dantuma N.P., Taylor J.P. VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy 2010, 6:217-227.
116. Ossareh-Nazari B., Bonizec M., Cohen M., Dokudovskaya S., Delalande F., Schaeffer C., Van Dorsselaer A., Dargemont C. Cdc48 and Ufd3, new partners of the ubiquitin protease Ubp3, are required for ribophagy. EMBO Rep. 2010, 11:548-554.
117. Krick R., Bremer S., Welter E., Schlotterhose P., Muehe Y., Eskelinen E.L., Thumm M. Cdc48/p97 and Shp1/p47 regulate autophagosome biogenesis in concert with ubiquitin-like Atg8. J. Cell Biol. 2010, 190:965-973.
118. Ravikumar B., Sarkar S., Davies J.E., Futter M., Garcia-Arencibia M., Green-Thompson Z.W., Jimenez-Sanchez M., Korolchuk V.I., Lichtenberg M., Luo S., Massey D.C., Menzies F.M., Moreau K., Narayanan U., Renna M., Siddiqi F.H., Underwood B.R., Winslow A.R., Rubinsztein D.C. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol. Rev. 2010, 90:1383-1435.
119. Pleasure I.T., Black M.M., Keen J.H. Valosin-containing protein, VCP, is a ubiquitous clathrin-binding protein. Nature 1993, 365:459-462.
120. Ritz D., Vuk M., Kirchner P., Bug M., Schutz S., Hayer A., Bremer S., Lusk C., Baloh R.H., Lee H., Glatter T., Gstaiger M., Aebersold R., Weihl C.C., Meyer H. Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP and UBXD1 and impaired by VCP disease mutations. Nat. Cell Biol. 2011, 13:1116-1123.
121. Berg T.O., Fengsrud M., Stromhaug P.E., Berg T., Seglen P.O. Isolation and characterization of rat liver amphisomes. Evidence for fusion of autophagosomes with both early and late endosomes. J. Biol. Chem. 1998, 273:21883-21892.
122. Razi M., Chan E.Y., Tooze S.A. Early endosomes and endosomal coatomer are required for autophagy. J. Cell Biol. 2009, 185:305-321.
123. Tooze J., Hollinshead M., Ludwig T., Howell K., Hoflack B., Kern H. In exocrine pancreas, the basolateral endocytic pathway converges with the autophagic pathway immediately after the early endosome. J. Cell Biol. 1990, 111:329-345.
124. Sato M., Sato K. Dynamic regulation of autophagy and endocytosis for cell remodeling during early development. Traffic 2013, 14:479-486.
125. Tracy K., Baehrecke E.H. The role of autophagy in Drosophila metamorphosis. Curr. Top. Dev. Biol. 2013, 103:101-125.
126. Yamanaka K., Okubo Y., Suzaki T., Ogura T. Analysis of the two p97/VCP/Cdc48p proteins of Caenorhabditis elegans and their suppression of polyglutamine-induced protein aggregation. J. Struct. Biol. 2004, 146:242-250.
127. Nishikori S., Yamanaka K., Sakurai T., Esaki M., Ogura T. p97 homologs from Caenorhabditis elegans, CDC-48.1 and CDC-48.2, suppress the aggregate formation of huntingtin exon1 containing expanded polyQ repeat. Genes Cells 2008, 13:827-838.
128. Kobayashi T., Manno A., Kakizuka A. Involvement of valosin-containing protein (VCP)/p97 in the formation and clearance of abnormal protein aggregates. Genes Cells 2007, 12:889-901.
129. Koike M., Fukushi J., Ichinohe Y., Higashimae N., Fujishiro M., Sasaki C., Yamaguchi M., Uchihara T., Yagishita S., Ohizumi H., Hori S., Kakizuka A. Valosin-containing protein (VCP) in novel feedback machinery between abnormal protein accumulation and transcriptional suppression. J. Biol. Chem. 2010, 285:21736-21749.
130. Ju J.S., Miller S.E., Hanson P.I., Weihl C.C. Impaired protein aggregate handling and clearance underlie the pathogenesis of p97/VCP-associated disease. J. Biol. Chem. 2008, 283:30289-30299.
131. Taylor J.P., Tanaka F., Robitschek J., Sandoval C.M., Taye A., Markovic-Plese S., Fischbeck K.H. Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. Hum. Mol. Genet. 2003, 12:749-757.
132. Higashiyama H., Hirose F., Yamaguchi M., Inoue Y.H., Fujikake N., Matsukage A., Kakizuka A. Identification of ter94, Drosophila VCP, as a modulator of polyglutamine-induced neurodegeneration. Cell Death Differ. 2002, 9:264-273.
133. Thoms S. Cdc48 can distinguish between native and non-native proteins in the absence of cofactors. FEBS Lett. 2002, 520:107-110.
134. Yang H., Liu C., Zhong Y., Luo S., Monteiro M.J., Fang S. Huntingtin interacts with the cue domain of gp78 and inhibits gp78 binding to ubiquitin and p97/VCP. PLoS One 2010, 5:e8905.
135. Mizuno Y., Hori S., Kakizuka A., Okamoto K. Vacuole-creating protein in neurodegenerative diseases in humans. Neurosci. Lett. 2003, 343:77-80.
136. Chapman E., Fry A.N., Kang M. The complexities of p97 function in health and disease. Mol. Biosyst. 2011, 7:700-710.
137. Halawani D., Tessier S., Anzellotti D., Bennett D.A., Latterich M., LeBlanc A.C. Identification of Caspase-6-mediated processing of the valosin containing protein (p97) in Alzheimer's disease: a novel link to dysfunction in ubiquitin proteasome system-mediated protein degradation. J. Neurosci. 2010, 30:6132-6142.
138. Nalbandian A., Llewellyn K.J., Kitazawa M., Yin H.Z., Badadani M., Khanlou N., Edwards R., Nguyen C., Mukherjee J., Mozaffar T., Watts G., Weiss J., Kimonis V.E. The homozygote VCP(R155H/R155H) mouse model exhibits accelerated human VCP-associated disease pathology. PLoS One 2012, 7:e46308.
139. Watts G.D., Wymer J., Kovach M.J., Mehta S.G., Mumm S., Darvish D., Pestronk A., Whyte M.P., Kimonis V.E. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 2004, 36:377-381.
140. Weihl C.C., Temiz P., Miller S.E., Watts G., Smith C., Forman M., Hanson P.I., Kimonis V., Pestronk A. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 2008, 79:1186-1189.
141. Kimonis V.E., Fulchiero E., Vesa J., Watts G. VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder. Biochim. Biophys. Acta 2008, 1782:744-748.
142. Forman M.S., Mackenzie I.R., Cairns N.J., Swanson E., Boyer P.J., Drachman D.A., Jhaveri B.S., Karlawish J.H., Pestronk A., Smith T.W., Tu P.H., Watts G.D., Markesbery W.R., Smith C.D., Kimonis V.E. Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations. J. Neuropathol. Exp. Neurol. 2006, 65:571-581.
143. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., Lee V.M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133.
144. Ju J.S., Weihl C.C. p97/VCP at the intersection of the autophagy and the ubiquitin proteasome system. Autophagy 2010, 6:283-285.
145. Nalbandian A., Donkervoort S., Dec E., Badadani M., Katheria V., Rana P., Nguyen C., Mukherjee J., Caiozzo V., Martin B., Watts G.D., Vesa J., Smith C., Kimonis V.E. The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis. J. Mol. Neurosci. 2011, 45:522-531.
146. Halawani D., LeBlanc A.C., Rouiller I., Michnick S.W., Servant M.J., Latterich M. Hereditary inclusion body myopathy-linked p97/VCP mutations in the NH2 domain and the D1 ring modulate p97/VCP ATPase activity and D2 ring conformation. Mol. Cell. Biol. 2009, 29:4484-4494.
147. Ju J.S., Weihl C.C. Inclusion body myopathy, Paget's disease of the bone and fronto-temporal dementia: a disorder of autophagy. Hum. Mol. Genet. 2010, 19:R38-R45.
148. Fernandez-Saiz V., Buchberger A. Imbalances in p97 co-factor interactions in human proteinopathy. EMBO Rep. 2010, 11:479-485.
149. Tang W.K., Li D., Li C.C., Esser L., Dai R., Guo L., Xia D. A novel ATP-dependent conformation in p97 N-D1 fragment revealed by crystal structures of disease-related mutants. EMBO J. 2010, 29:2217-2229.
150. Erzurumlu Y., Aydin Kose F., Gozen O., Gozuacik D., Toth E.A., Ballar P. A unique IBMPFD-related P97/VCP mutation with differential binding pattern and subcellular localization. Int. J. Biochem. Cell Biol. 2013, 45:773-782.
151. Manno A., Noguchi M., Fukushi J., Motohashi Y., Kakizuka A. Enhanced ATPase activities as a primary defect of mutant valosin-containing proteins that cause inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia. Genes Cells 2010, 15:911-922.
152. Weihl C.C., Dalal S., Pestronk A., Hanson P.I. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation. Hum. Mol. Genet. 2006, 15:189-199.
153. Imamura S., Yabu T., Yamashita M. Protective role of cell division cycle 48 (CDC48) protein against neurodegeneration via ubiquitin-proteasome system dysfunction during zebrafish development. J. Biol. Chem. 2012, 287:23047-23056.
154. Muller J.M., Deinhardt K., Rosewell I., Warren G., Shima D.T. Targeted deletion of p97 (VCP/CDC48) in mouse results in early embryonic lethality. Biochem. Biophys. Res. Commun. 2007, 354:459-465.
155. Badadani M., Nalbandian A., Watts G.D., Vesa J., Kitazawa M., Su H., Tanaja J., Dec E., Wallace D.C., Mukherjee J., Caiozzo V., Warman M., Kimonis V.E. VCP associated inclusion body myopathy and paget disease of bone knock-in mouse model exhibits tissue pathology typical of human disease. PLoS One 2010, 5.
156. Ching J.K., Weihl C.C. Rapamycin-induced autophagy aggravates pathology and weakness in a mouse model of VCP-associated myopathy. Autophagy 2013, 9.
157. Ching J.K., Elizabeth S.V., Ju J.S., Lusk C., Pittman S.K., Weihl C.C. mTOR dysfunction contributes to vacuolar pathology and weakness in valosin-containing protein associated inclusion body myopathy. Hum. Mol. Genet. 2013, 22:1167-1179.
158. Gamerdinger M., Hajieva P., Kaya A.M., Wolfrum U., Hartl F.U., Behl C. Protein quality control during aging involves recruitment of the macroautophagy pathway by BAG3. EMBO J. 2009, 28:889-901.
159. Shaid S., Brandts C.H., Serve H., Dikic I. Ubiquitination and selective autophagy. Cell Death Differ. 2012, 20:21-30.
160. Pratt A.J., Getzoff E.D., Perry J.J. Amyotrophic lateral sclerosis: update and new developments. Degener. Neurol. Neuromuscul. Dis. 2012, 2012:1-14.
161. Johnson J.O., Mandrioli J., Benatar M., Abramzon Y., Van Deerlin V.M., Trojanowski J.Q., Gibbs J.R., Brunetti M., Gronka S., Wuu J., Ding J., McCluskey L., Martinez-Lage M., Falcone D., Hernandez D.G., Arepalli S., Chong S., Schymick J.C., Rothstein J., Landi F., Wang Y.D., Calvo A., Mora G., Sabatelli M., Monsurro M.R., Battistini S., Salvi F., Spataro R., Sola P., Borghero G., Galassi G., Scholz S.W., Taylor J.P., Restagno G., Chio A., Traynor B.J. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 2010, 68:857-864.
162. Zou Z.Y., Liu M.S., Li X.G., Cui L.Y. Screening of VCP mutations in Chinese amyotrophic lateral sclerosis patients. Neurobiol. Aging 2013, 34:1519. (e1513-1514).
163. Abramzon Y., Johnson J.O., Scholz S.W., Taylor J.P., Brunetti M., Calvo A., Mandrioli J., Benatar M., Mora G., Restagno G., Chio A., Traynor B.J. Valosin-containing protein (VCP) mutations in sporadic amyotrophic lateral sclerosis. Neurobiol. Aging 2012, 33. (2231 e2231-2231 e2236).
164. Song C.Y., Guo J.F., Liu Y., Tang B.S. Autophagy and its comprehensive impact on ALS. Int. J. Neurosci. 2012, 122:695-703.
165. Ghosal G., Leung J.W., Nair B.C., Fong K.W., Chen J. Proliferating cell nuclear antigen (PCNA)-binding protein C1orf124 is a regulator of translesion synthesis. J. Biol. Chem. 2012, 287:34225-34233.
166. Haines D.S. p97-containing complexes in proliferation control and cancer: emerging culprits or guilt by association?. Genes Cancer 2010, 1:753-763.
167. Liu Y., Hei Y., Shu Q., Dong J., Gao Y., Fu H., Zheng X., Yang G. VCP/p97, down-regulated by microRNA-129-5p, could regulate the progression of hepatocellular carcinoma. PLoS One 2012, 7:e35800.
168. Asai T., Tomita Y., Nakatsuka S., Hoshida Y., Myoui A., Yoshikawa H., Aozasa K. VCP (p97) regulates NFkappaB signaling pathway, which is important for metastasis of osteosarcoma cell line. Jpn. J. Cancer Res. 2002, 93:296-304.
169. Yamamoto S., Tomita Y., Nakamori S., Hoshida Y., Nagano H., Dono K., Umeshita K., Sakon M., Monden M., Aozasa K. Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence. J. Clin. Oncol. 2003, 21:447-452.
170. Valle C.W., Min T., Bodas M., Mazur S., Begum S., Tang D., Vij N. Critical role of VCP/p97 in the pathogenesis and progression of non-small cell lung carcinoma. PLoS One 2011, 6:e29073.
171. Abaan O.D., Hendriks W., Uren A., Toretsky J.A., Erkizan H.V. Valosin containing protein (VCP/p97) is a novel substrate for the protein tyrosine phosphatase PTPL1. Exp. Cell Res. 2012, 319:1-11.
172. Yi P., Higa A., Taouji S., Bexiga M.G., Marza E., Arma D., Castain C., Le Bail B., Simpson J., Rosenbaum J., Balabaud C., Bioulac-Sage P., Blanc J.F., Chevet E. Sorafenib-mediated targeting of the AAA+ ATPase p97/VCP leads to disruption of the secretory pathway, endoplasmic reticulum stress and hepatocellular cancer cell death. Mol. Cancer Ther. 2012, 11:2610-2620.
173. Byun H., Halani N., Mertz J.A., Ali A.F., Lozano M.M., Dudley J.P. Retroviral Rem protein requires processing by signal peptidase and retrotranslocation for nuclear function. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:12287-12292.
174. Hauler F., Mallery D.L., McEwan W.A., Bidgood S.R., James L.C. AAA ATPase p97/VCP is essential for TRIM21-mediated virus neutralization. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:19733-19738.
175. Ewens C.A., Kloppsteck P., Forster A., Zhang X., Freemont P.S. Structural and functional implications of phosphorylation and acetylation in the regulation of the AAA+ protein p97. Biochem. Cell Biol. 2010, 88:41-48.
176. den Besten W., Verma R., Kleiger G., Oania R.S., Deshaies R.J. NEDD8 links cullin-RING ubiquitin ligase function to the p97 pathway. Nat. Struct. Mol. Biol. 2012, 19:511-516. (S511).
177. Kim N.C., Tresse E., Kolaitis R.M., Molliex A., Thomas R.E., Alami N.H., Wang B., Joshi A., Smith R.B., Ritson G.P., Winborn B.J., Moore J., Lee J.Y., Yao T.P., Pallanck L., Kundu M., Taylor J.P. VCP Is Essential for Mitochondrial Quality Control by PINK1/Parkin and this Function Is Impaired by VCP Mutations. Neuron 2013, 78:65-80.
178. Bartolome F., Wu H.C., Burchell V.S., Preza E., Wray S., Mahoney C.J., Fox N.C., Calvo A., Canosa A., Moglia C., Mandrioli J., Chio A., Orrell R.W., Houlden H., Hardy J., Abramov A.Y., Plun-Favreau H. Pathogenic VCP Mutations Induce Mitochondrial Uncoupling and Reduced ATP Levels. Neuron 2013, 78:57-64.